Delivering real-time solutions for COVID-19
In the midst of a global health crisis, particularly one involving a highly contagious virus like SARS-CoV-2, fast results at the point of care can enable healthcare professionals and patients to make informed decisions that help slow the spread of COVID-19 and even save lives.
On-site actionable results can make a difference
From rapid antigen tests, to blood gas solutions, to our comprehensive portfolio of products for monitoring cardiac, metabolic, and kidney function—our point of care solutions are everywhere where rapid, real-time results are needed.
Siemens Healthineers Point of Care is committed to providing our customers with the resources and diagnostic tools they need to care for their patients during this challenging global pandemic and beyond
CLINITEST® Rapid COVID-19 Antigen Test:
*In the U.S., for use under Emergency Use Authorization only. Distributed by Siemens Healthineers.
*Not available for sale in the U.S. Product availability varies by country
Studies have shown that patients with chronic conditions are at greater risk for more severe complications and worse outcomes if they contract COVID-19.1-4
Our portfolio of operator-friendly, trustworthy, and versatile analyzers can:
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
Knights H, Mayor N, Millar K, et al. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clinical Medicine. 2020Sep;20(5).
Rovere-Querini P, De Lorenzo R, Conte C, et al. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(Suppl 9):22-8.
Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020;164:108214. https://doi.org/10.1016/j.diabres.2020.108214.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395;1054-62.